Rooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Novo Nordisk plans to build a manufacturing facility in North Carolina to help address the need for injectable treatments for chronic diseases and weight loss.
The Danish company says the expansion will add 1.4 million square feet of production space, which is double that of its existing facilities in the state. It will also reportedly add 1,000 jobs. “This is yet another real signal of our efforts to scale up our production to meet the growing global need for our life-changing medicines and the patients of tomorrow," said Lars Fruergaard Jørgensen, president and CEO of Novo Nordisk.Novo Nordisk is the drugmaker behind name brands including Ozempic and Wegovy. The popular drugs, which treat diabetes and weight loss, have been subject to shortages due to their popularity.
A KFF survey found that about 1 in 8 Americans have used GLP-1 agonist drugs like Ozempic and Wegovy. Novo Nordisk believes this new facility will help avoid shortages in the future. Construction is expected to be completed in phases between 2027 and 2029.Related Story: The secret to weight loss that drug companies don't want you to know
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, OzempicThe new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy, Ozempic and other drugs.
Read more »
Ozempic and Wegovy may reduce inflammation by targeting the brainWeight-loss injections such as Wegovy reduce inflammation in the body by acting on brain cells, according to a study in mice
Read more »
Fake Wegovy and Ozempic warnings: What to knowWHO and Eli Lilly has warned consumers to be cautious of counterfeit versions of popular weight-loss and diabetes drugs like Wegovy, Ozempic being sold online.
Read more »
Bernie Sanders: Ozempic, Wegovy drugmaker is 'ripping off' U.S. over weight loss drug costBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Texas patients turn to clinics for compounded semaglutide with Ozempic and WeGovy scarceAfter Ozempic and Wegovy burst onto the market in 2021 after gaining FDA approval for weight loss, 1 in 8 Americans have tried the pricey medications to cut...
Read more »